No Record Found
Sector
PharmaceuticalsOpen
₹880Prev. Close
₹882.6Turnover(Lac.)
₹1,521.87Day's High
₹882.6Day's Low
₹857.4552 Week's High
₹94352 Week's Low
₹636.1Book Value
₹106.37Face Value
₹1Mkt Cap (₹ Cr.)
18,126.22P/E
74.52EPS
11.62Divi. Yield
08 Aug 2025
12:00 AM
AGM
Announcement Date: 08 Aug, 2025
21 Jul 2025
12:00 AM
Board Meeting
Agenda : Audited Result
The estimated sale value of these shares is about ₹2,500 Crore. As per reports, the transaction shall take place at a floor price of ₹860 per share.
Here are some of the stocks that may see significant price movement today: IREDA, Tata Motors, Sai Life Sciences, etc.
The IPO that was opened between December 11 and December 13, 2024 aggregates to ₹3,042.62 crore and has had a price band of ₹533-549 per equity share.
Investors can bid for up to 27 shares in a single lot, with the company setting a price range of Rs 522-549 per share.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 20.89 | 17.66 | 17.62 | 17.23 |
Preference Capital | 0 | 0.87 | 0.39 | 0.39 |
Reserves | 2,146.58 | 993.15 | 894.72 | 873.42 |
Net Worth | 2,167.47 | 1,011.68 | 912.73 | 891.04 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Gross Sales | 1,694.57 | 1,465.18 | 1,217.14 | 869.59 |
Excise Duty | 0 | 0 | 0 | 0 |
Net Sales | 1,694.57 | 1,465.18 | 1,217.14 | 869.59 |
Other Operating Income | 0 | 0 | 0 | 0 |
Other Income | 36.78 | 29.09 | 27.97 | 28.15 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,631.2 | 78.71 | 3,92,063.33 | 753.53 | 0.98 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 5,866 | 66.67 | 1,55,749.09 | 557 | 0.51 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,517.7 | 23.7 | 1,22,429.01 | 1,303.13 | 1.06 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,514.7 | 59.82 | 1,18,922.69 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,248.1 | 15.11 | 1,04,168.14 | 2,961.2 | 0.64 | 7,788.7 | 345.74 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Exec. Director
Ranga Raju Kanumuri
Managing Director & CEO
Krishnamraju Kanumuri
Independent Non Exe. Director
Ramesh Iyer
Independent Non Exe. Director
Suchita Sharma
Independent Non Exe. Director
Dinesh V Patel
Whole Time Director & CFO
SIVARAMAKRISHNAN CHITTOR
Company Sec. & Compli. Officer
RUNA KUMAR
Plot #.DS-7 IKP Knowledge Park,
Turkapally (V) Shameerpet Md,
Telangana - 500078
Tel: +91 40 6815 6000
Website: http://www.sailife.com
Email: investors@sailife.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@kfintech.com
Summary
Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at H...
Read More
Reports by Sai Life Sciences Ltd
What is the Sai Life Sciences Ltd share price today?
What is the Market Cap of Sai Life Sciences Ltd?
What is the PE and PB ratio of Sai Life Sciences Ltd?
What is the 52 Week High and Low of Sai Life Sciences Ltd?
What is the CAGR of Sai Life Sciences Ltd?
What is the shareholding pattern of Sai Life Sciences Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
